NABsys Inc
Nanopore-based platform for detecting structural variants in DNA
- Sector
- Biotech
- Headquarters
- Providence, RI
- Latest Form D
- $25.5M, Aug 2014
- Total capital
- $67.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $67.5M
- 3 Form D · last Aug 2014
- 146 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 16 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$25.5M
- Private capital raisedForm D · SEC · 2nd filing$35M
- Private capital raisedForm D · SEC · 1st filing$7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Barrett BreadyDirectorNamed in SEC Form D filings
- David MartiranoDirectorNamed in SEC Form D filings
- Gina RaimondoDirectorNamed in SEC Form D filings
- John OliverExecutive OfficerNamed in SEC Form D filings
- Leroy HoodDirectorNamed in SEC Form D filings
- Lionel CarnotDirectorNamed in SEC Form D filings
Show all 11 people
- Peter LewisExecutive OfficerNamed in SEC Form D filings
- Ray StataDirectorNamed in SEC Form D filings
- Stan RoseDirectorNamed in SEC Form D filings
- Steve LombardiExecutive Officer, DirectorNamed in SEC Form D filings
- William GerberDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 16- PendingDistance Maps Using Multiple Alignment Consensus ConstructionUSPTOApplication 14212458
- PendingDistance Maps Using Multiple Alignment Consensus ConstructionUSPTOApplication PCTUS2014027751
- PendingMethods And Systems For Electronic KaryotypingUSPTOApplication PCTUS2014021756
Show all 16 patent records
- Distance Maps Using Multiple Alignment Consensus ConstructionSep 18, 2014 · Application 14212458Pending
- Distance Maps Using Multiple Alignment Consensus ConstructionApplication PCTUS2014027751Pending
- Methods And Systems For Electronic KaryotypingApplication PCTUS2014021756Pending
- Enhanced Probe BindingApplication PCTUS2014011829Pending
- Method And System For Analysis Of Protein And Other Modifications On Dna And RnaApplication PCTUS2013061651Pending
- Method And System For Electronic KaryotypingApplication 61787138Pending
- Use Of Longitudinally Displaced Nanoscale Electrodes For Voltage Sensing Of Biomolecules And Other Analytes In Fluidic ChannelsApplication 61782990Pending
- Method And System For Analysis Of Protein And Other Modifications On Dna And RnaApplication 61774216Pending
- Method And System For Analysis Of Protein/dna And Protein/rna InteractionsApplication 61705983Pending
- Assay Methods Using Dna Binding ProteinsApplication PCTUS2012024708Pending
- Methods For Sequencing A Biomolecule By Detecting Relative Positions Of Hybridized ProbesApplication PCTUS2011059933Pending
- Assay Methods Using Nicking EndonucleasesApplication PCTUS2011053274Pending
- Devices And Methods For Analyzing Biomolecules And Prones Bound TheretoApplication PCTUS2010028848Pending
- Use Of Longitudinally Displaced Nanoscale Electrodes For Voltage Sensing Of Biomolecules And Other Analytes In Fluidic ChannelsApplication PCTUS2009055876Pending
- Enhanced Probe BindingApplication 61754258Pending
- Devices And Methods For Determining The Length Of Biopolymers And Distances Between Probes Bound TheretoApplication PCTUS2009055878Pending
Related companies, and why
- Arcturus BiotherapeuticsSimilar federal contract value in Biotech · null in contracts
- Crossbow TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Phoenix Animal Wellness, Inc.Similar federal contract value in Biotech · null in contracts
- Unity BiotechnologySimilar federal contract value in Biotech · null in contracts
- INFLAMED, INC.Similar federal contract value in Biotech · null in contracts
- Apellis Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .